Form 4 for PCRX Pacira BioSciences, Inc.
Accepted 2022-10-11 00:00:00 ET · period of report 2022-10-07 · accession 0001209191-22-053275 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-10-11 | 2022-10-07 | PCRX | REINHARDT MAX | Pres, Rest of World | S - Sale | $58.00 | -1,380 | 31.4K | -4% | -$80.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-07 | S | D | 1,380 | $58.00 | 31,378 | D | — | — | (F2) Includes 408 shares of common stock acquired under the issuer's employee stock purchase plan in June 2022. |